Skip to main content
Nxera Pharma Co., Ltd. (TYO:4565)
Japan flag Japan · Delayed Price · Currency is JPY
926.00
-24.00 (-2.53%)
Jun 6, 2025, 3:30 PM JST

Nxera Pharma Revenue

Nxera Pharma had revenue of 6.64B JPY in the quarter ending March 31, 2025, with 44.09% growth. This brings the company's revenue in the last twelve months to 30.87B, up 87.83% year-over-year. In the year 2024, Nxera Pharma had annual revenue of 28.84B with 125.87% growth.

Revenue (ttm)
30.87B
Revenue Growth
+87.83%
P/S Ratio
2.77
Revenue / Employee
79.76M
Employees
374
Market Cap
85.41B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202428.84B16.07B125.87%
Dec 31, 202312.77B-2.80B-18.00%
Dec 31, 202215.57B-2.14B-12.10%
Dec 31, 202117.71B8.87B100.32%
Dec 31, 20208.84B-884.00M-9.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Chugai Pharmaceutical 1,222.12B
Daiichi Sankyo Company 1,886.26B
Takeda Pharmaceutical Company 4,581.55B
HOYA Corporation 869.37B
Terumo 1,036.17B
Otsuka Holdings 2,393.18B
Astellas Pharma 1,912.32B
Olympus 997.33B
Revenue Rankings

Nxera Pharma News

More News